AIRLINK 62.48 Increased By ▲ 2.05 (3.39%)
BOP 5.36 Increased By ▲ 0.01 (0.19%)
CNERGY 4.58 Decreased By ▼ -0.02 (-0.43%)
DFML 15.50 Increased By ▲ 0.66 (4.45%)
DGKC 66.40 Increased By ▲ 1.60 (2.47%)
FCCL 17.59 Increased By ▲ 0.73 (4.33%)
FFBL 27.70 Increased By ▲ 2.95 (11.92%)
FFL 9.27 Increased By ▲ 0.21 (2.32%)
GGL 10.06 Increased By ▲ 0.10 (1%)
HBL 105.70 Increased By ▲ 1.49 (1.43%)
HUBC 122.30 Increased By ▲ 4.78 (4.07%)
HUMNL 6.60 Increased By ▲ 0.06 (0.92%)
KEL 4.50 Decreased By ▼ -0.05 (-1.1%)
KOSM 4.48 Decreased By ▼ -0.09 (-1.97%)
MLCF 36.20 Increased By ▲ 0.79 (2.23%)
OGDC 122.92 Increased By ▲ 0.53 (0.43%)
PAEL 23.00 Increased By ▲ 1.09 (4.97%)
PIAA 29.34 Increased By ▲ 2.05 (7.51%)
PIBTL 5.80 Decreased By ▼ -0.14 (-2.36%)
PPL 107.50 Increased By ▲ 0.13 (0.12%)
PRL 27.25 Increased By ▲ 0.74 (2.79%)
PTC 18.07 Increased By ▲ 1.97 (12.24%)
SEARL 53.00 Decreased By ▼ -0.63 (-1.17%)
SNGP 63.21 Increased By ▲ 2.01 (3.28%)
SSGC 10.80 Increased By ▲ 0.05 (0.47%)
TELE 9.20 Increased By ▲ 0.71 (8.36%)
TPLP 11.44 Increased By ▲ 0.86 (8.13%)
TRG 70.86 Increased By ▲ 0.95 (1.36%)
UNITY 23.62 Increased By ▲ 0.11 (0.47%)
WTL 1.28 No Change ▼ 0.00 (0%)
BR100 6,944 Increased By 65.8 (0.96%)
BR30 22,827 Increased By 258.6 (1.15%)
KSE100 67,142 Increased By 594.3 (0.89%)
KSE30 22,090 Increased By 175.1 (0.8%)
Business & Finance

Pfizer says working on new COVID-19 vaccine supply deal to Israel

  • Pfizer and its partner BioNTech agreed in November to supply Israel with an undisclosed number of COVID-19 vaccines and Israel's Finance Ministry has said it paid some 2.6 billion shekels ($785 million).
  • Israel's government is seeking to secure 36 million more Pfizer/BioNTech doses for use as booster shots or for children once they are eligible, but that hit a snag last week over political infighting.
Published April 5, 2021

JERUSALEM: Pfizer said on Monday it was working on a new deal to supply COVID-19 vaccines to Israel after an initial supply agreement forged in late 2020 has ended.

Pfizer and its partner BioNTech agreed in November to supply Israel with an undisclosed number of COVID-19 vaccines and Israel's Finance Ministry has said it paid some 2.6 billion shekels ($785 million).

To date, 5.27 million Israelis above the age of 16 have received a first dose, while 4.84 million have received a second shot - out of a population of 9.3 million. Some Israelis have also received doses of Moderna's vaccine, giving the country one of the highest inoculation rates in the world.

Israel's government is seeking to secure 36 million more Pfizer/BioNTech doses for use as booster shots or for children once they are eligible, but that hit a snag last week over political infighting.

The cabinet last week was set to approve the purchase, at around 3.5 billion shekels, but it was called off in a squabble between Prime Minister Benjamin Netanyahu and his defence minister, Benny Gantz, who heads a rival party, over judicial appointments.

The Jerusalem Post reported that a shipment of 700,000 doses was set to arrive on Sunday but was halted after the state failed to approve transfer of payment for the previous 2.5 million doses Pfizer/BioNTech had supplied.

Pfizer did not comment on the report but in an emailed response to Reuters, it said it had completed all deliveries to Israel under its initial agreement to provide its COVID-19 vaccine, signed in November 2020.

"The company is currently working with the Israeli government to update the agreement, to supply additional vaccines to the country. While this work continues, shipments may be adjusted," Pfizer said.

Comments

Comments are closed.